News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MEDA: Acquisition of Acton Pharmaceuticals, Inc. Completed


10/21/2013 10:05:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

On August 30th, 2013, Meda (STO:MEDAA) announced the acquisition of Acton Pharmaceuticals, Inc. and its proprietary product Aerospan. The acquisition has now been completed. The purchase price for Acton amounted to 135 MUSD, on a cash and debt free basis. In addition, there is a milestone payment of 10 million USD and royalty based milestones.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES